NDC 68547-211 - Xacduro
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68547-211
- Package NDCs from labels
- 68547-211-20
- Manufacturer
- La Jolla Pharmaceutical Company | Entasis Therapeutics Inc. (ETI)
- Effective date
- 2025-11-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xacduro - La Jolla Pharmaceutical Company | Entasis Therapeutics Inc. (ETI) | La Jolla Pharmaceutical Company | Entasis Therapeutics Inc. (ETI) | 2025-11-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | adc92303-b62b-41c8-becf-9c3a4e8c3a6b | 2025-08-12 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | 2709e9fc-2341-4382-af72-c2e3201bd77a | 2025-08-12 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin Sodium and Sulbactam Sodium | AMPICILLIN SODIUM, SULBACTAM SODIUM | Armas Pharmaceuticals Inc. | ac6f8158-9d7e-4b99-af3c-0407c5287b57 | 2025-07-31 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | 9f2ff165-2a21-4155-a4f0-57885a83c7dc | 2025-07-24 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Avenacy, LLC | 577dd6f0-d56a-4c82-9f72-274c3a4a0f01 | 2025-04-25 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Avenacy, LLC | 4446d4c8-056d-4bc3-8f58-21255b063398 | 2025-04-25 | Warnings, Adverse reactions | DKQ4T82YE6 |
| ampicillin and sulbactam | AMPICILLIN AND SULBACTAM | Sagent Pharmaceuticals | 35606b43-5914-423c-9bc7-fa3957eb2563 | 2024-11-18 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | NorthStar Rx, LLC | 5e8d35cb-e93d-42ad-a02c-0dbf04910f61 | 2024-08-13 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | NorthStar Rx, LLC | 1e5004f1-e79e-4e0b-9f3f-25f6bbc15255 | 2024-06-27 | Warnings, Adverse reactions | DKQ4T82YE6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.